| [18 F] AV-1451 binding and postmortem pathology of CBD. S Coakeley, LC Ang, GH Jansen, SS Cho, AE Lang, S Houle, LV Kalia, ... Movement disorders: official journal of the Movement Disorder Society 33 (8 …, 2018 | 6 | 2018 |
| [18F]-AV-1451 Binding to neuromelanin in the substantia nigra in PD and PSP S Coakeley, SS Cho, Y Koshimori, P Rusjan, A Lang, L Kalia, E Slow, ... MOVEMENT DISORDERS 32, S51-S51, 2017 | 39 | 2017 |
| A New Chapter for the Journal of Parkinson’s Disease LV Kalia, BR Bloem Journal of Parkinson's Disease 12 (5), 1365-1367, 2022 | | 2022 |
| A novel C. elegans model for identification of small molecules that target alpha-synuclein-mediated toxicity LV Kalia, K Menezes, Y Zhang, S Ishikura, N Tran, H Chau, AM Lozano, ... Movement Disorders 31, S256, 2016 | | 2016 |
| A novel peptide reduces a-synuclein levels and neurodegeneration in cell, invertebrate, and mammalian models of Parkinson's disease D O'Hara, S Nim, K Hall, M Kapadia, M De Snoo, H Chau, S Ngana, ... MOVEMENT DISORDERS 35, S228-S228, 2020 | | 2020 |
| A Randomized Controlled Trial of Fecal Microbiota Transplantation for Parkinson’s Disease: Getting it right, if not PARFECT M Beckers, B Coburn, LV Kalia, BR Bloem Journal of Parkinson's Disease, 1-3, 0 | | |
| A rodent model for direct visualization of alpha-synuclein oligomers in the nigrostriatal system LV Kalia, H Dimant, SK Kalia, LN Kibuuka, D Ebrahimi-Fakhari, ... MOVEMENT DISORDERS 27, S484-S484, 2012 | | 2012 |
| Addressing the “Replication Crisis” in the Field of Parkinson’s Disease F Albanese, BR Bloem, LV Kalia Journal of Parkinson's Disease 13 (6), 849, 2023 | | 2023 |
| Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort M Cressatti, GD Pinilla-Monsalve, M Blais, CP Normandeau, C Degroot, ... medRxiv, 2024.05. 10.24307196, 2024 | | 2024 |
| Alpha-synuclein as a potential biomarker and therapeutic target for parkinson's disease L Kalia JOURNAL OF NEUROCHEMISTRY 150, 35-35, 2019 | 3 | 2019 |
| An Intelligent Diagnosis: SMART Syndrome LB Day, P Rajendram, LV Kalia, WL Gold The American Journal of Medicine 134 (7), 863-865, 2021 | | 2021 |
| Anatomy and Physiology of the Brain LV Kalia Metabolism of Human Diseases: Organ Physiology and Pathophysiology, 5, 2014 | | 2014 |
| Animal models of [alpha]-synucleinopathy for Parkinson disease drug development JB Koprich, LV Kalia, JM Brotchie Nature Reviews Neuroscience 18 (9), 515-529, 2017 | 227 | 2017 |
| BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62 EL Friesen, YT Zhang, R Earnshaw, ML De Snoo, DM O’Hara, V Agapova, ... Frontiers in Cell and Developmental Biology 8, 716, 2020 | 7 | 2020 |
| Barriers to women clinician-scientists: a trainee's perspective. LV Kalia Clinical and investigative medicine. Médecine clinique et experimentale 26 …, 2003 | 2 | 2003 |
| Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice TF Outeiro, LV Kalia, E Bezard, J Ferrario, CH Lin, M Salama, ... Movement Disorders, 2024 | | 2024 |
| Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell death ML De Snoo, EL Friesen, YT Zhang, R Earnshaw, G Dorval, M Kapadia, ... Cell Death & Disease 10 (12), 907, 2019 | 35 | 2019 |
| Bcl-2-相关的致癌基因家庭成员对帕金依赖性线粒体的调节 M Kapadia, ML De Snoo, LV Kalia, SK Kalia 中国神经再生研究 (英文版) 16 (4), 684, 2021 | | 2021 |
| Biomarkers for cognitive dysfunction in Parkinson's disease LV Kalia Parkinsonism & related disorders 46, S19-S23, 2018 | 53 | 2018 |
| Botulinum Toxin-Associated Prolonged Remission of Idiopathic Cervical Dystonia G Saranza, KHS Chen, C Ganos, LV Kalia, R Chen, AE Lang Canadian Journal of Neurological Sciences 48 (6), 864-868, 2021 | 2 | 2021 |
